Advancing cardiovascular risk assessment with secretoneurin

A blood biomarker providing incremental prognostic information in cardiovascular disease

Menu

Advancing cardiovascular risk assessment with secretoneurin

A blood biomarker providing incremental prognostic information in cardiovascular disease

Advancing cardiovascular risk assessment with secretoneurin

A blood biomarker providing incremental prognostic information in cardiovascular disease

Menu

Advancing cardiovascular risk assessment with secretoneurin

A blood biomarker providing incremental prognostic information in cardiovascular disease

What we do

Developing highly specific secretoneurin assays for cardiovascular research and diagnostic testing

What is secretoneurin (SN)

Secretoneurin (SN) is a 33-amino acid peptide derived from secretogranin II, expressed in neuroendocrine tissues and the myocardium, and associated with pathophysiological processes relevant to cardiovascular disease.

Secretoneurin assays

CardiNor offers a highly specific secretoneurin CE-IVD ELISA assay, with high-throughput solutions currently under development.

Access & collaboration

CardiNor has partnerships and a global network of distributors to make secretoneurin assays available to laboratories worldwide.

Clinical studies support the prognostic relevance of secretoneurin in cardiovascular disease.

© 2026

Visiting address

c/o Horisont, Lørenveien 73A, 0585 Oslo

Part of

Visiting address

c/o Horisont, Lørenveien 73A, 0585 Oslo

Part of

Visiting address

c/o Horisont, Lørenveien 73A, 0585 Oslo

Part of

© 2026

Visiting address

c/o Horisont, Lørenveien 73A, 0585 Oslo

Part of